Novartis Sues To Reverse USPTO Judgment

Law360, New York (January 9, 2007, 12:00 AM EST) -- A Novartis AG subsidiary has filed a federal lawsuit against two French research institutions, seeking to overturn an unfavorable judgment in a patent interference proceeding before a U.S. Patent and Trademark Office board.

The lawsuit, filed on Friday by California-based Novartis Vaccines and Diagnostics Inc., names the Institut Pasteur and Centre Nationale De La Recherche Scientifique as defendants.

Pursuant to 35 U.S.C. section 146, any party to a USPTO interference can file a civil action seeking review of the USPTO’s decision within 60 days of the...
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.